股市必读：海翔药业（002099）8月5日主力资金净流出877.82万元

Group 1 - The stock price of Haixiang Pharmaceutical (002099) closed at 6.27 yuan on August 5, 2025, with a slight increase of 0.16% and a turnover rate of 0.96% [1] - On August 5, the net outflow of main funds was 877.82 million yuan, while retail investors saw a net inflow of 683.46 million yuan [2][4] - The company announced a share repurchase plan on April 9, 2025, with a total repurchase amount set between 150 million yuan and 300 million yuan, and a maximum repurchase price of 7.46 yuan per share [2] Group 2 - On August 5, 2025, Haixiang Pharmaceutical repurchased 850,000 shares through centralized bidding, accounting for 0.05% of the total share capital, with a total transaction amount of 5,326,664 yuan [2][4] - The company plans to continue the repurchase based on market conditions and will fulfill its information disclosure obligations [2]